The presence of TX/NX/MX indicate unknown tumor extent. We will add this to the recommendation.
Problem is that not all cancers are following this logic.
Examples:
Stage IVA prostate cancer is Any T, N1, M0. No metastasis here. We cannot categorize them as metastatic disease
Stage IVA bladder cancer: T4b, Any N, M0 OR Any T, Any N, M1a. A mix of metastatic and non-metastatic bladder cancer. We cannot tell who is metastatic and who is not based on the stage.
Stage II thyroid cancer: Any T, Any N, M1 (in patients <55 years old). Metastatic but using stage categories, we would categorize it as invasive disease.
ENCR has tumor specific recommendation for deriving disease extent from T, N and M values. We have considered this options as well. We are still evaluating this option and other options including SEER Summary stage as potential options. Please bring any recommendation/suggestion to the Onc WG meetings and help us finalize the recommendations.
I wasn’t sure whether this was a straightforward thing or whether it was more complicated (and maybe still under discussion). I see that it is the latter . I will have a look at it with Chiara and we’ll bring any suggestions we have to the Onc WG meeting.